XTSX
JNH
Market cap291kUSD
Jun 06, Last price
0.01CAD
Name
Jack Nathan Medical Corp
Chart & Performance
P/E
0.06
P/S
0.05
EPS
0.18
Div Yield, %
—
Shrs. gr., 5y
100.72%
Rev. gr., 5y
%
Revenues
9m
-54.52%
Net income
7m
P
CFO
-6m
L+4.16%
Earnings
Jul 10, 2026
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Jack Nathan Medical Corp. (JNH.V), along with its affiliated entities, primarily delivers primary healthcare services under the Jack Nathan Health brand. These medical clinics are predominantly located within Walmart Supercentres. As of June 30, 2022, the company managed a substantial network of facilities: In Canada, 76 clinics were situated inside Walmart locations across various provinces, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Quebec. Additionally, the Canadian portfolio included 4 standalone clinics operating independently of Walmart, alongside 18 general medical clinics, 2 rehabilitation centers, and 5 MedSpa facilities. In Mexico, Jack Nathan Medical Corp. had a significant presence with 108 corporate-owned and operated clinics, all established within Walmart Supercentres. The company was founded in 2006 and has its corporate headquarters situated in Woodbridge, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2025‑01 | 2024‑01 | 2023‑01 | 2022‑01 | 2021‑01 | 2020‑01 | 2019‑12 | 2018‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||